vancomycin-resistant enterococci Genome Sequencing, EHR Machine Learning Method Detects Unnoticed Hospital Outbreaks Premium Researchers demonstrated that their method, called EDS-HAT, can pick up outbreaks in hospitals that would otherwise remain undetected. Pathogenic, Drug-Resistant Bacteria Isolated from UK Wastewater Treatment Facilities Sequencing analysis of the Enterococcus faecium isolates found that they belonged to two clades, one of which harbored numerous resistance genes. Bacterial Test from iCubate Well-Suited for Small, Medium Labs, Study Says Premium Collaborators said that the test is accurate and reliable for the rapid detection of the most common gram-positive bacteria responsible for bloodstream infections. Following First FDA Approval for MDx Platform, iCubate Has Eye on Point-of-Care Market Premium The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content iCubate Receives CE Mark for Dx Platform, Bloodstream Infection Assay Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark. Aug 10, 2017 FDA Clears iCubate System, Bloodstream Infection Assay Jul 21, 2017 Startup SpinDiag Raises €1.6M in Seed Funding Mar 17, 2017 Genomic Analysis Traces Transplant Recipient Infection Back to Donor Feb 24, 2017 Genome Sequences Show How Hospital-Acquired Bloodstream Infections Are Transmitted Mar 27, 2014 IMDx VanR Assay for Abbott MDx System Cleared in Canada, Singapore Jan 30, 2014 As HPV Business Slows, Qiagen Looks to MDx Menu Expansion, Other Initiatives to Drive Growth Premium Jul 29, 2013 FDA Clears IMDx's MDx for Vancomycin-resistant Enterococci Sep 22, 2011 Dx Focus Sep 22, 2011: Clinical and Regulatory PCR and Nucleic Acid Testing News Premium Jul 21, 2011 Canon, U of Maryland Co-Developing Infectious Disease MDx System Premium Jun 23, 2010 Molecular Detection Raises $1.4M in Follow-on Funding Premium Feb 4, 2010 Cepheid Places Next-Gen PCR Systems at VA Hospitals; Cites MRSA Tests as 'Key' Business Driver Premium Jan 11, 2010 Cepheid Shares Spike on Analyst Upgrade Jan 6, 2010 Cepheid Gets FDA Nod for Antimicrobial Resistance Test Jan 6, 2010 Cepheid to Launch FDA-Cleared Healthcare-Associated Infection Test Xpert vanA by End of Month Premium Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.